Evaluate the expected performance of Novartis (NVS) for the quarter ended December 2025, looking beyond the conventional Wall ...
Negotiated prices for Kisqali and Verzenio, which the agency said cost Medicare over $1 billion in a year, would become effective starting 2028.
Globally, CARDIO4Cities — initiated by the Novartis Foundation — has been deployed across more than 40 cities including São ...
Health and Me on MSN
India loses a woman to breast cancer every eight minutes: Novartis’ ‘Take Charge’ campaign aims to change that
Breast cancer is now the most common cancer among Indian women, with younger women increasingly affected. The ‘Take Charge’ ...
The creation of a 700,000-square-foot flagship manufacturing hub marks the continuation of our investment in the US, enabling us to more reliably reach patients across the country. As Novartis ...
The pharma giant will invest in a 35,000-square-foot RLT manufacturing site in Winter Park, FL as part of its $23 billion US ...
The business of manufacturing never stops. Industrial companies merge, invest and strategically expand to keep competitive, even under adverse business conditions. Read on for more details on five ...
With that in mind, let's consider three dividend stocks to buy this year and stick with for good: Visa ( V 0.70%), Novartis ( NVS +0.09%), and Meta Platforms ( META +1.15%). Visa, a favorite ...
Tourmaline went public in 2023 via a reverse merger with the struggling cell therapy developer Talaris. The deal gave Tourmaline funds to develop pacibekitug, an antibody that targets interleukin-6, a ...
As Novartis turns the calendar on a new year, the Swiss drugmaker is elaborating further on plans for the $23 billion U.S. investment it unveiled last April. Next on the docket will be a new, ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results